Inj. Pantop (Pantoprazole Injection)
Pantop is a branded IV formulation of pantoprazole sodium, a proton pump inhibitor (PPI). It's a substituted benzimidazole in the same class as omeprazole, esomeprazole, lansoprazole, and rabeprazole (brand: Protonix in the US) - Lippincott Illustrated Reviews: Pharmacology, p. 1416.
Mechanism of action
Pantoprazole is a prodrug that accumulates in the acidic canaliculi of gastric parietal cells, where it's activated and irreversibly binds to the H+/K+-ATPase (the "proton pump"), blocking the final step of gastric acid secretion regardless of the stimulus (histamine, gastrin, or acetylcholine) - Katzung's Basic and Clinical Pharmacology, 16th Ed.
Formulation
- Delayed-release oral tablets and oral suspension also exist, but Inj. Pantop is the IV form, used when oral intake isn't possible or rapid acid suppression is needed - Goodman & Gilman's Pharmacological Basis of Therapeutics.
Clinical indications for IV use
- Upper GI bleeding (peptic ulcer, stress ulcer prophylaxis) - this is the most common reason for the injectable form:
- Active bleeding (hematemesis, hemodynamic instability): pantoprazole 80 mg IV bolus
- No active bleeding: pantoprazole 40 mg IV
- If endoscopy delayed beyond 12 hours: a second 40 mg IV dose
- (Source: Sabiston Textbook of Surgery, Table 98.1, "Overview of Upper GI Bleeding")
- GERD, erosive esophagitis, peptic ulcer disease, Zollinger-Ellison syndrome, and H. pylori eradication regimens (typically switched to oral once tolerating feeds)
- Stress ulcer prophylaxis in critically ill/ICU patients unable to take oral medication
Adverse effects / precautions
PPIs as a class (including pantoprazole) carry risk of:
- Headache, diarrhea, nausea
- Long-term use: risk of B12/magnesium/calcium deficiency, increased fracture risk, C. difficile infection, and rebound acid hypersecretion on withdrawal
- Drug interactions: reduces absorption of drugs needing acidic pH (e.g., certain antifungals); can interfere with clopidogrel activation to a lesser extent than omeprazole
Dose tapering (when discontinuing long-term therapy)
A stepped taper is used in chronic PPI users:
- Pantoprazole 40 mg BD → 20 mg BD → 20 mg OD → stop, tapering over roughly 2 months per step, with PRN supply for symptom flares (Scott-Brown's Otorhinolaryngology, Box 77.6).
Recent evidence check
A 2024 systematic review/network meta-analysis found pantoprazole performed well for preventing peptic ulcer recurrence in low-dose aspirin users (PMID: 38252210), consistent with standard textbook guidance - no contradicting recent evidence found.
If you meant a specific clinical scenario (e.g., dosing for a particular patient, pediatric use, or renal/hepatic adjustment), let me know and I can go deeper.